The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|30|4493-4554

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.30, 2017-11, pp. : 4493-4554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus

By  

Current Pharmaceutical Design, Vol. 20, Iss. 21, 2014-05 ,pp. : 3465-3477

Bentham Science Publishers

Access to resources Recommend Favorite

Macrocyclic Inhibitors of HCV NS3-4A Protease: Design and Structure Activity Relationship

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 13, 2007-07 ,pp. : 1290-1301

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1403-1422

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Modelling in Studies for Hepatitis C Virus (HCV) NS3 Protease

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 12, 2016-03 ,pp. : 1351-1361

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Hepatitis C Virus NS3.4A Protease: P2 Proline Variants

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-01 ,pp. : 497-502

Bentham Science Publishers

Access to resources Recommend Favorite